Abbott Laboratories buy Benchmark Co.
Start price
17.04.26
/
50%
€81.24
Target price
17.04.27
€101.90
Performance (%)
22.92%
Price
21.08.26
€99.86
Summary
This prediction is currently active. The prediction currently has a performance of 22.92%. This prediction currently runs until 17.04.27. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 1.368% | 1.368% |
| iShares Core DAX® | -1,59 % | 5,03 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % |
| iShares S&P 500 | -3,23 % | 0,47 % |
Comments by Benchmark_Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (ABT) had its price target lowered by Benchmark Co. from $145.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.06
10.10.25
10.10.25
€125.35
10.10.26
10.10.26
-13.21%
21.08.26
21.08.26

